Results showed that treatment with abaloparatide for 12 months resulted in significant increases in bone mineral density compared with placebo. The Food and Drug Administration (FDA) has approved ...

Radius Health, Inc. RDUS announced positive top-line data from the phase III ATOM study which is evaluating its lead product, Tymlos (abaloparatide 80 mg subcutaneous [“SC”]) injection, for use in men ...

Tymlos can cause mild to serious side effects. Examples include dizziness, injection site reaction, and nausea. In most cases, side effects caused by Tymlos are temporary. For most people, mild side ...

The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has rejected the marketing application for abaloparatide (Radius Health) ...

A person may receive injections for osteoporosis, but there are no options available for annual injections. However, some people may receive a yearly infusion for osteoporosis. The type of treatment ...

Mild side effects of Tymlos include dizziness, headache, and fatigue. Mild side effects are usually temporary, lasting a few days to weeks. While rare, Tymlos may cause serious side effects such as ...